{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T00:31:59Z","timestamp":1721867519732},"reference-count":12,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,7,24]]},"DOI":"10.7759\/cureus.65274","type":"journal-article","created":{"date-parts":[[2024,7,24]],"date-time":"2024-07-24T14:31:50Z","timestamp":1721831510000},"source":"Crossref","is-referenced-by-count":0,"title":["A Rare Case of Atypical Hemolytic Uremic Syndrome Presenting as Chronic Interstitial Nephritis"],"prefix":"10.7759","author":[{"given":"Shruthi","family":"Muralidharan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerry G","family":"Mathew","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anand","family":"Alwan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Varadharajan","family":"Jayaprakash","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.4081\/hr.2017.7053","article-title":"Atypical hemolytic uremic syndrome: a brief review","volume":"9","author":"Zhang K","year":"2017","unstructured":"Zhang K, Lu Y, Harley KT, Tran MH. Atypical hemolytic uremic syndrome: a brief review. Hematol Rep. 2017, 9:7053. 10.4081\/hr.2017.7053","journal-title":"Hematol Rep"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-09-109876","article-title":"Factor H autoantibodies in atypical hemolytic uremic syndrome correlate with CFHR1\/CFHR3 deficiency","volume":"111","author":"J\u00f3zsi M","year":"2008","unstructured":"J\u00f3zsi M, Licht C, Strobel S, et al.. Factor H autoantibodies in atypical hemolytic uremic syndrome correlate with CFHR1\/CFHR3 deficiency. Blood. 2008, 111:1512-4. 10.1182\/blood-2007-09-109876","journal-title":"Blood"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.5527\/wjn.v4.i1.31","article-title":"Complement activation in progressive renal disease","volume":"4","author":"Fearn A","year":"2015","unstructured":"Fearn A, Sheerin NS. Complement activation in progressive renal disease. World J Nephrol. 2015, 4:31-40. 10.5527\/wjn.v4.i1.31","journal-title":"World J Nephrol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2014.168","article-title":"Complement activation in the tubulointerstitium: AKI, CKD, and in between","volume":"86","author":"Brar JE","year":"2014","unstructured":"Brar JE, Quigg RJ. Complement activation in the tubulointerstitium: AKI, CKD, and in between. Kidney Int. 2014, 86:663-6. 10.1038\/ki.2014.168","journal-title":"Kidney Int"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.2147\/JMDH.S245620","article-title":"Atypical hemolytic-uremic syndrome: genetic basis, clinical manifestations, and a multidisciplinary approach to management","volume":"16","author":"Yerigeri K","year":"2023","unstructured":"Yerigeri K, Kadatane S, Mongan K, et al.. Atypical hemolytic-uremic syndrome: genetic basis, clinical manifestations, and a multidisciplinary approach to management. J Multidiscip Healthc. 2023, 16:2233-49. 10.2147\/JMDH.S245620","journal-title":"J Multidiscip Healthc"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.radcr.2023.02.035","article-title":"Hemolytic uremic syndrome with central nervous system manifestations, a case report and literature review","volume":"18","author":"Mansour MA","year":"2023","unstructured":"Mansour MA, Khalil DF, Hasham MA, Youssef A, Rashad M, Awadallah M, Ali H. Hemolytic uremic syndrome with central nervous system manifestations, a case report and literature review. Radiol Case Rep. 2023, 18:2268-73. 10.1016\/j.radcr.2023.02.035","journal-title":"Radiol Case Rep"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3174\/ajnr.A1280","article-title":"MR imaging findings in 56 patients with Wernicke encephalopathy: nonalcoholics may differ from alcoholics","volume":"30","author":"Zuccoli G","year":"2009","unstructured":"Zuccoli G, Santa Cruz D, Bertolini M, Rovira A, Gallucci M, Carollo C, Pipitone N. MR imaging findings in 56 patients with Wernicke encephalopathy: nonalcoholics may differ from alcoholics. AJNR Am J Neuroradiol. 2009, 30:171-6. 10.3174\/ajnr.A1280","journal-title":"AJNR Am J Neuroradiol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1053\/j.sult.2010.03.002","article-title":"Differential diagnosis of T2 hyperintense brainstem lesions: Part 2. Diffuse lesions","volume":"31","author":"Guzm\u00e1n-De-Villoria JA","year":"2010","unstructured":"Guzm\u00e1n-De-Villoria JA, Ferreiro-Arg\u00fcelles C, Fern\u00e1ndez-Garc\u00eda P. Differential diagnosis of T2 hyperintense brainstem lesions: Part 2. Diffuse lesions. Semin Ultrasound CT MR. 2010, 31:260-74. 10.1053\/j.sult.2010.03.002","journal-title":"Semin Ultrasound CT MR"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-05-221549","article-title":"Association of factor H autoantibodies with deletions of CFHR1, CFHR3, CFHR4, and with mutations in CFH, CFI, CD46, and C3 in patients with atypical hemolytic uremic syndrome","volume":"115","author":"Moore I","year":"2010","unstructured":"Moore I, Strain L, Pappworth I, et al.. Association of factor H autoantibodies with deletions of CFHR1, CFHR3, CFHR4, and with mutations in CFH, CFI, CD46, and C3 in patients with atypical hemolytic uremic syndrome. Blood. 2010, 115:379-87. 10.1182\/blood-2009-05-221549","journal-title":"Blood"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/cei.12426","article-title":"Complement activation patterns in atypical haemolytic uraemic syndrome during acute phase and in remission","volume":"181","author":"Volokhina EB","year":"2015","unstructured":"Volokhina EB, Westra D, van der Velden TJ, van de Kar NC, Mollnes TE, van den Heuvel LP. Complement activation patterns in atypical haemolytic uraemic syndrome during acute phase and in remission. Clin Exp Immunol. 2015, 181:306-13. 10.1111\/cei.12426","journal-title":"Clin Exp Immunol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.4274\/tjh.2013.0374","article-title":"Atypical hemolytic uremic syndrome: differential diagnosis from TTP\/HUS and management","volume":"31","author":"Yenerel MN","year":"2014","unstructured":"Yenerel MN. Atypical hemolytic uremic syndrome: differential diagnosis from TTP\/HUS and management. Turk J Haematol. 2014, 31:216-25. 10.4274\/tjh.2013.0374","journal-title":"Turk J Haematol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ekir.2018.11.010","article-title":"Eculizumab use for kidney transplantation in patients with a diagnosis of atypical hemolytic uremic syndrome","volume":"4","author":"Siedlecki AM","year":"2019","unstructured":"Siedlecki AM, Isbel N, Vande Walle J, James Eggleston J, Cohen DJ. Eculizumab use for kidney transplantation in patients with a diagnosis of atypical hemolytic uremic syndrome. Kidney Int Rep. 2019, 4:434-46. 10.1016\/j.ekir.2018.11.010","journal-title":"Kidney Int Rep"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/272122-a-rare-case-of-atypical-hemolytic-uremic-syndrome-presenting-as-chronic-interstitial-nephritis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,24]],"date-time":"2024-07-24T14:31:53Z","timestamp":1721831513000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/272122-a-rare-case-of-atypical-hemolytic-uremic-syndrome-presenting-as-chronic-interstitial-nephritis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,24]]},"references-count":12,"URL":"https:\/\/doi.org\/10.7759\/cureus.65274","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7,24]]}}}